Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections

about

Ranibizumab-induced retinal reperfusion and regression of neovascularization in diabetic retinopathy: An angiographic illustration.

P2860

Q50323605-1085C52D-F521-4EBD-AF3A-EF26D89DC313

P2860

Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections

Item

http://www.wikidata.org/entity/Q37608621

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Retinal reperfusion in diabeti ...... i-VEGF intravitreal injections

@en

Retinal reperfusion in diabeti ...... -VEGF intravitreal injections.

@nl

type

Item

label

Retinal reperfusion in diabeti ...... i-VEGF intravitreal injections

@en

Retinal reperfusion in diabeti ...... -VEGF intravitreal injections.

@nl

prefLabel

Retinal reperfusion in diabeti ...... i-VEGF intravitreal injections

@en

Retinal reperfusion in diabeti ...... -VEGF intravitreal injections.

@nl

P1476

Retinal reperfusion in diabeti ...... i-VEGF intravitreal injections

@en

P2093

Anton Orlin

http://www.w3.org/2001/XMLSchema#string

Ariana M Levin

http://www.w3.org/2001/XMLSchema#string

Donald J D'Amico

http://www.w3.org/2001/XMLSchema#string

Irene Rusu

http://www.w3.org/2001/XMLSchema#string

Mrinali P Gupta

http://www.w3.org/2001/XMLSchema#string

Peter Coombs

http://www.w3.org/2001/XMLSchema#string

Szilárd Kiss

http://www.w3.org/2001/XMLSchema#string

P2860

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Reperfusion of occluded capillary beds in diabetic retinopathy.

Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study.

Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.

Increased expression of basement membrane collagen in human diabetic retinopathy.

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.

Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate.

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

P304

193-200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OPTH.S118807

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28176934

http://www.w3.org/2001/XMLSchema#string

P932

5268366

http://www.w3.org/2001/XMLSchema#string

Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections

about

P2860

P2860

Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932